The Effect of Ziyin Xiaozheng Hugan Formula on Laboratory Indicators and Quality of Life in Patients with Primary Liver Cancer after Hepatic Artery Chemotherapy Embolization
JIAO Yingqiang
SUN Yunchao
GUO Na
XU Shubin
GE Jianli
ZHANG Xin
Abstract：Objective To investigate the effect of Ziyin Xiaozheng Hugan Formula on laboratory indicators and quality of life in patients with primary liver cancer undergoing transarterial chemoembolization(TACE).Methods 64 patients with primary liver cancer(PLC)were randomly divided into two groups:the control group(32 cases)received conventional TACE treatment,and symptomatic treatments such as liver protection,analgesia,and antiemetic treatment were given after surgery;on the basis of treatment in the control group,the traditional Chinese medicine group(32 cases)was treated with oral Ziyin Xiaozheng Hugan Formula for one month.Record the levels of alpha fetoprotein(AFP),carcinoembryonic antigen(CEA),serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),gamma glutamyl transferase(GGT),alkaline phosphatase(ALP),and plasma prothrombin time(PT)of two groups of patients before and one month after surgery,and compare the overall quality of life of the two groups of patients after surgery.Results The levels of AFP,CEA,ALT,AST,GGT,ALP,and PT in the traditional Chinese medicine group were significantly lower than those in the control group one month after surgery(P<0.05);The overall quality of life score of the traditional Chinese medicine group after surgery was higher than that of the control group,but the difference was not statistically significant(P>0.05).Conclusion On the basis of conventional TACE surgery,postoperative combination of nourishing yin,eliminating symptoms,and protecting the liver formula can improve patients'liver function and reduce laboratory indicators such as AFP,CEA,and PT.
Keywords：Ziyin Xiaozheng Hugang Formulaprimary liver cancerhepatic artery chemoembolizationquality of lifeliver functionlaboratory indicators
Publication Date：2025-11-20
Online Publishing Date：2026-07-17(First online date of this platform, not the publication date of the document)
Pages：5( 61-65 )